Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for chronic low back pain
ACTRN12621001453875Phase 3Recruiting
- Sponsor
- Prof Flavia Cicuttini
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic low back pain (CLBP) comparing Metformin with Placebo (2 arms). Primary endpoint: Change in current back pain intensity. Started May 2022; status: recruiting.
02
Drugs
metformin
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on ACTRN12621001453875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621001453875.